Protein Expression Market Industry Trends and Global Forecasts to 2035: Since 2023, Over 6,500 Patents Related to Protein Expression have been Granted
September 27, 2024 11:55 ET
|
Research and Markets
Dublin, Sept. 27, 2024 (GLOBE NEWSWIRE) -- The "Protein Expression Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Protein Expression System, Protein Expression-related...
Biognosys Enters Reselling Agreement for Spectronaut Proteomics Software with Leading Provider of Mass Spectrometry Systems
September 18, 2024 10:00 ET
|
Biognosys AG
Biognosys Enters Reselling Agreement for Spectronaut® Proteomics Software with Leading Provider of Mass Spectrometry Systems
Europe Protein Expression Market Research 2024: Increasing Demand for Protein Biologics Creating the Need for Protein Expression - Forecasts to 2033
August 22, 2024 10:09 ET
|
Research and Markets
Dublin, Aug. 22, 2024 (GLOBE NEWSWIRE) -- The "Europe Protein Expression Market: Focus on Application, End User, Product, Expression System, and Country - Analysis and Forecast, 2023-2033" report...
Protein Crystallization Market Report 2024: Trends, Forecast and Competitive Analysis to 2030 - A $1.6 Billion Industry Driven by Advances in Protein Crystallography Techniques
August 22, 2024 04:01 ET
|
Research and Markets
Dublin, Aug. 22, 2024 (GLOBE NEWSWIRE) -- The "Protein Crystallization Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
Olink® Introduces Global Network of Certified Service Providers to Accelerate Protein Biomarker Discovery
July 03, 2024 08:00 ET
|
Olink Proteomics AB
Inaugural network of Olink® Certified Service Providers includes eading contract research organizations (CROs) and service labs around the world.
Protein Engineering Industry to Cross $7.8 Billion by 2030 - Discover the Key Trends, Drivers, and Market Players Shaping the Future Landscape
June 19, 2024 04:07 ET
|
Research and Markets
Dublin, June 19, 2024 (GLOBE NEWSWIRE) -- The "Protein Engineering - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Protein...
Chemomab Therapeutics Announces New Publications Reinforcing the Clinical Potential of Its CCL24-Neutralizing Antibody CM-101 in Primary Sclerosing Cholangitis
June 18, 2024 07:00 ET
|
Chemomab Therapeutics
New publication confirms the role of CCL24 in primary sclerosing cholangitis and the potential of CM-101 to impact PSC disease progression and severity.
Global Protein Expression Market Report 2024-2032
June 12, 2024 10:51 ET
|
Research and Markets
Dublin, June 12, 2024 (GLOBE NEWSWIRE) -- The "Global Protein Expression Market Report by Product, Application, End User, and Region 2024-2032" report has been added to ResearchAndMarkets.com's...
Chemomab Therapeutics Presents Data Supporting the Clinical Potential of CM-101 as a Novel Treatment for Primary Sclerosing Cholangitis at EASL 2024 and a Gordon Research Conference
June 06, 2024 07:00 ET
|
Chemomab Therapeutics
Chemomab presents new data supporting clinical potential of CM-101 as novel treatment for PSC at EASL 2024 and Gordon Research Conference
Biognosys launches groundbreaking P2 Plasma Enrichment technology for unbiased, deep plasma proteomics at ASMS 2024
May 30, 2024 09:15 ET
|
Biognosys AG
Biognosys launches single-well, single particle-type P2 Plasma Enrichment technology with market-leading performance for unbiased, deep plasma proteomics